Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
How scientists are shining light on the biology behind seasonal affective disorder
2/11/2025
I tested 13 travel pillows on buses, trains and arcade machines : here are my favourites
2/11/2025
Even when unthinkable things were happening to me, my first instinct was to work. Am I addicted ?
1er/11/2025
Jess Cartner-Morley’s November style essentials : from chic raincoats to the perfect party trousers
1er/11/2025
Raw milk, tomahawk steak and a cuddly toy : could I handle Erling Haaland’s daily routine ?
1er/11/2025
M&S launches ‘secret support’ pants that offer men a ‘subtle lift’
31/10/2025